[{"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.062,"PropertyPlantAndEquipmentNet_0_Q1_USD":31294000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":16119000.0,"ProfitLoss_1_Q1_USD":-42974000.0,"LiabilitiesCurrent_0_Q1_USD":62065000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":584276000.0,"Liabilities_0_Q1_USD":189861000.0,"InterestAndOtherIncome_1_Q1_USD":1548000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5620000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":5321000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":87249000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":5620000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":85749000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":3775000.0,"LettersOfCreditOutstandingAmount_0_Q1_USD":1500000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":43580000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":71075000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":5000000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":272381000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":277381000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q1_USD":272381000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1096854000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q1_USD":5000000.0,"GainLossOnTerminationOfLease_1_Q1_USD":0.0,"Goodwill_0_Q1_USD":38550000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":116060000.0,"StockholdersEquity_0_Q1_USD":394291000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":5880000.0,"ShareBasedCompensation_1_Q1_USD":5620000.0,"RestrictedCashNoncurrent_0_Q1_USD":1500000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":1500000.0,"DebtSecuritiesAvailableForSaleRealizedLoss_1_Q1_USD":0.0,"ResearchAndDevelopmentExpense_1_Q1_USD":41479000.0,"VariableLeaseCost_1_Q1_USD":500000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":75377000.0,"OperatingLeasePayments_1_Q1_USD":1600000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":40198000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3299000.0,"OperatingLeaseLiability_0_Q1_USD":43497000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":409000.0,"OperatingLeaseCost_1_Q1_USD":2600000.0,"OperatingIncomeLoss_1_Q1_USD":-44522000.0,"OperatingExpenses_1_Q1_USD":57598000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":82000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-699898000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":13076000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.37,"GoodwillImpairmentLoss_1_Q1_USD":0.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":394415000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":411000.0,"OtherNoncashIncomeExpense_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":13023000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":6385000.0,"CommonStockValue_0_Q1_USD":1163000.0,"PreferredStockValue_0_Q1_USD":0.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AssetsCurrent_0_Q1_USD":370948000.0,"Assets_0_Q1_USD":584276000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":75274000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":36550000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1311000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":744000.0,"AccountsReceivableNetCurrent_0_Q1_USD":6970000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":8592000.0,"IncreaseDecreaseInPrepaidRent_1_Q1_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":254000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":169000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":16923000.0,"InterestReceivableCurrent_0_Q1_USD":926000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":14849728.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-4965000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q1_USD":1633000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-1633000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":6444000.0,"OtherAssetsNoncurrent_0_Q1_USD":9470000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":100000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4922000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":345000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-29939000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":6463000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":6551000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":6689000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":26134000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":56520000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":820000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":52137000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-3828000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":276794000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":123000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":710000.0,"MinorityInterest_0_Q1_USD":124000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":1080000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-8319000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":-61000.0,"NetIncomeLoss_1_Q1_USD":-42913000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-18890000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":23720000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":409000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-44353000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":-61000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-44292000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_1_Q1_USD":244000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":4298000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"Ticker":"SGMO","CIK":"1001233","name":"SANGAMO THERAPEUTICS, INC","OfficialName":"Sangamo Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"pure","footnote":"nan","Market Cap":"750923571.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]